Search

Author/Creator Hudis, Clifford A

1. Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial. Issue 3 (March 2023)

Authors:
Tolaney, Sara M; Tarantino, Paolo; Graham, Noah; Tayob, Nabihah; Parè, Laia; Villacampa, Guillermo; Dang, Chau T; Yardley, Denise A; Moy, Beverly; Marcom, P Kelly; Albain, Kathy S; Rugo, Hope S; Ellis, Matthew J; Shapira, Iuliana; Wolff, Antonio C; Carey, Lisa A; Barroso-Sousa, Romualdo; Villagra...
Journal:
Lancet oncology
Issue:
Volume 24:Issue 3(2023)
Page Start:
273
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Physical Activity, Weight, and Outcomes in Patients Receiving Chemotherapy for Metastatic Breast Cancer (C40502/Alliance). Issue 3 (12th April 2021)

Authors:
Ligibel, Jennifer A; Huebner, Luke; Rugo, Hope S; Burstein, Harold J; Toppmeyer, Debra L; Anders, Carey K; Ma, Cynthia; Barry, William T; Suman, Vera; Carey, Lisa A; Partridge, Ann H; Hudis, Clifford A; Winer, Eric P
Journal:
JNCI cancer spectrum
Issue:
Volume 5:Issue 3(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Pre-operative immunotherapy with tumor cryoablation (cryo) plus ipilimumab (ipi) induces potentially favorable systemic and intratumoral immune effects in early stage breast cancer (ESBC) patients. (14th August 2015)

Authors:
Page, David B; Diab, Adi; Yuan, Jianda; Dong, Zhiwan; Soloman, Stephen B; Patil, Sujata; Hudis, Clifford A; Wolchok, Jedd D; Norton, Larry; McArthur, Heather L
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3(2015)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗